Spot Trading L.L.C - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$628,000
+119.6%
69,952
+31.4%
0.01%
+160.0%
Q2 2016$286,000
+61.6%
53,252
+38.8%
0.01%
+25.0%
Q1 2016$177,000
-94.5%
38,378
-93.8%
0.00%
-88.2%
Q4 2015$3,238,000
+145.7%
622,654
+185.9%
0.03%
+161.5%
Q3 2015$1,318,000
-57.0%
217,808
+12.3%
0.01%
-53.6%
Q2 2015$3,063,000
-22.4%
193,987
-46.6%
0.03%
-28.2%
Q1 2015$3,947,000
-0.3%
363,113
-3.5%
0.04%
+56.0%
Q4 2014$3,959,000
+42.0%
376,411
+29.4%
0.02%
+92.3%
Q3 2014$2,789,000
-14.1%
290,778
+3.4%
0.01%
-13.3%
Q2 2014$3,248,000281,2200.02%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2015
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders